Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$2.47 - $5.55 $580,403 - $1.3 Million
-234,981 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$2.63 - $4.12 $28,990 - $45,414
-11,023 Reduced 4.48%
234,981 $618,000
Q2 2021

Aug 05, 2021

BUY
$3.94 - $5.44 $709,428 - $979,515
180,058 Added 273.04%
246,004 $1.02 Million
Q1 2021

May 10, 2021

BUY
$4.61 - $9.04 $304,011 - $596,151
65,946 New
65,946 $311,000
Q2 2020

Aug 11, 2020

SELL
$8.05 - $14.21 $116,121 - $204,979
-14,425 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$6.8 - $14.66 $233,913 - $504,289
-34,399 Reduced 70.46%
14,425 $132,000
Q4 2019

Feb 12, 2020

BUY
$12.82 - $16.85 $308,885 - $405,983
24,094 Added 97.43%
48,824 $681,000
Q3 2019

Nov 12, 2019

BUY
$16.31 - $28.29 $403,346 - $699,611
24,730 New
24,730 $426,000
Q2 2019

Aug 06, 2019

SELL
$19.18 - $27.88 $367,834 - $534,682
-19,178 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$8.0 - $19.66 $120,176 - $295,332
-15,022 Reduced 43.92%
19,178 $367,000
Q4 2018

Feb 12, 2019

BUY
$8.59 - $18.05 $293,778 - $617,310
34,200 New
34,200 $321,000
Q3 2018

Nov 13, 2018

SELL
$17.11 - $21.74 $520,144 - $660,896
-30,400 Closed
0 $0
Q2 2018

Aug 09, 2018

BUY
$16.76 - $23.92 $509,504 - $727,168
30,400 New
30,400 $594,000

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $223M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.